Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1966 1
1967 3
1968 1
1973 2
1974 2
1975 3
1976 2
1977 2
1978 1
1979 2
1981 5
1982 9
1983 2
1984 3
1985 5
1986 6
1987 1
1988 1
1989 3
1990 1
1991 1
1992 5
1993 7
1994 3
1995 4
1996 3
1997 8
1998 3
1999 7
2000 7
2001 10
2002 16
2003 5
2004 11
2005 11
2006 7
2007 6
2008 8
2009 7
2010 7
2011 8
2012 11
2013 12
2014 15
2015 13
2016 12
2017 14
2018 17
2019 12
2020 23
2021 24
2022 28
2023 30
2024 13

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

383 results

Results by year

Filters applied: . Clear all
Page 1
Enfortumab vedotin following platinum-based chemotherapy and immune checkpoint inhibitors for advanced urothelial carcinoma: response, survival and safety analysis from a multicentre real-world Japanese cohort.
Miyake M, Nishimura N, Oda Y, Miyamoto T, Ohmori C, Takamatsu N, Itami Y, Tachibana A, Matsumoto Y, Kiba K, Tomioka A, Yamamoto H, Okajima E, Masaomi K, Sakamoto K, Tomizawa M, Shimizu T, Ohnishi K, Hori S, Morizawa Y, Gotoh D, Nakai Y, Torimoto K, Tanaka N, Fujimoto K; Nara Urological Research and Treatment Group. Miyake M, et al. Among authors: tachibana a. Jpn J Clin Oncol. 2024 Mar 9;54(3):329-338. doi: 10.1093/jjco/hyad170. Jpn J Clin Oncol. 2024. PMID: 38061911
Rapidly growing oropharyngeal cancer with a 6-month course.
Minami R, Iizuka T, Tachibana A, Moriguchi Y, Noma E, Onishi T, Arakawa T, Horiguchi S. Minami R, et al. Among authors: tachibana a. Clin J Gastroenterol. 2023 Aug;16(4):550-553. doi: 10.1007/s12328-023-01796-9. Epub 2023 Apr 13. Clin J Gastroenterol. 2023. PMID: 37055609
Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial.
Ramacciotti E, Barile Agati L, Calderaro D, Aguiar VCR, Spyropoulos AC, de Oliveira CCC, Lins Dos Santos J, Volpiani GG, Sobreira ML, Joviliano EE, Bohatch Júnior MS, da Fonseca BAL, Ribeiro MS, Dusilek C, Itinose K, Sanches SMV, de Almeida Araujo Ramos K, de Moraes NF, Tierno PFGMM, de Oliveira ALML, Tachibana A, Chate RC, Santos MVB, de Menezes Cavalcante BB, Moreira RCR, Chang C, Tafur A, Fareed J, Lopes RD; MICHELLE investigators. Ramacciotti E, et al. Among authors: tachibana a. Lancet. 2022 Jan 1;399(10319):50-59. doi: 10.1016/S0140-6736(21)02392-8. Epub 2021 Dec 15. Lancet. 2022. PMID: 34921756 Free PMC article. Clinical Trial.
The interface sign.
Fonseca EKUN, Shoji H, Tachibana A, Funari MBG, Szarf G. Fonseca EKUN, et al. Among authors: tachibana a. Abdom Radiol (NY). 2019 Jan;44(1):372-373. doi: 10.1007/s00261-018-1680-3. Abdom Radiol (NY). 2019. PMID: 29946926 Review. No abstract available.
Serum high-sensitivity C-reactive protein and dementia in a community-dwelling Japanese older population (JPSC-AD).
Tachibana A, Iga JI, Ozaki T, Yoshida T, Yoshino Y, Shimizu H, Mori T, Furuta Y, Shibata M, Ohara T, Hata J, Taki Y, Mikami T, Maeda T, Ono K, Mimura M, Nakashima K, Takebayashi M, Ninomiya T, Ueno SI; JPSC-AD study group. Tachibana A, et al. Sci Rep. 2024 Mar 28;14(1):7374. doi: 10.1038/s41598-024-57922-1. Sci Rep. 2024. PMID: 38548879 Free PMC article.
Difference of oncological efficacy between two immune checkpoint inhibitors following first-line platinum-based chemotherapy in patients with unresectable, metastatic, advanced urothelial carcinoma: a multicenter real-world Japanese cohort.
Miyake M, Nishimura N, Oda Y, Miyamoto T, Iida K, Inoue K, Tachibana A, Yoshikawa T, Sakamoto K, Ohnishi M, Maesaka F, Takamatsu N, Mieda K, Ohmori C, Matsubara T, Tomizawa M, Shimizu T, Ohnishi K, Hori S, Morizawa Y, Gotoh D, Nakai Y, Torimoto K, Tanaka N, Fujimoto K; Nara Urological Research and Treatment Group. Miyake M, et al. Among authors: tachibana a. Int J Clin Oncol. 2024 Sep;29(9):1311-1325. doi: 10.1007/s10147-024-02573-5. Epub 2024 Jun 18. Int J Clin Oncol. 2024. PMID: 38888683
fMRI Validation of fNIRS Measurements During a Naturalistic Task.
Noah JA, Ono Y, Nomoto Y, Shimada S, Tachibana A, Zhang X, Bronner S, Hirsch J. Noah JA, et al. Among authors: tachibana a. J Vis Exp. 2015 Jun 15;(100):e52116. doi: 10.3791/52116. J Vis Exp. 2015. PMID: 26132365 Free PMC article.
383 results